Vorobyova D A, Lebedev A M, Vagida M S, Ivanova O I, Felker E I, Gontarenko V N, Shpektor A V, Margolis L B, Vasilieva E Yu
Laboratory of Atherothrombosis A.I. EvdokimovMoscow State University of Medicine and Dentistry, Moscow, Russia.
Department of vascular surgery of A.V. Vishnevsky Institute of Surgery, Moscow, Russia.
Kardiologiia. 2016 Dec;56(11):78-85. doi: 10.18565/cardio.2016.11.78-85.
to analyze the dynamics of lymphocytic composition of human atherosclerotic plaques in ex vivo culture system.
The study included 15 atherosclerotic plaques obtained from patients who underwent carotid endarterectomy. Plaques were cultured as ring-shaped explants on collagen rafts in culture medium of special composition in CO2 incubator according to the previously developed technique. On day 0, and also on the 4th and 19th days of culture we extracted cells from plaque explants and analyzed B- and T-lymphocytic content of the tissue, as well as the percentage of CD16+ natural killer (NK) cells, using multichromatic flow cytometry. For this purpose we digested the explants with an original enzymatic cocktail, which allows preservation of cell surface markers, and we stained extracted cells with fluorescence-labelled monoclonal antibodies against CD45, CD3, CD19, CD4, CD8, CD16. In addition, we estimated the amount of interleukin 2 (IL-2) and interferon-gamma (IFN-)-producing T-cells by means of flow cytometry.
After 4 days of culture the amount of lymphocytes in plaques explants decreased, however live lymphocytes were still preserved (2619.3 [1680.4, 3478.2] cells/100mg tissue). Viable lymphocytes population included T cells (2123.4 [484.9; 3181.2] cells/100 mg tissue), B cells (5.6 [3.4, 27.9] cell/100 mg tissue) and CD16+ NK cells (10.6 [1.8, 23.7] cell/100mg tissue). On the 4th day of culture T cells were presented by CD4+CD8- (797 [475.5, 1000.7] cells/100mg tissue, 37.5 [32.1; 46.3]%) and CD4-CD8+ (686.2 [423.6; 1158.4] cells/100 mg tissue, 45.6 [38.1; 47.9]%) populations. The percentage of CD4+CD8- T cell population decreased compared to the 1st day of culture, and this decrease correlated with the increase in CD4-CD8- T cells content (p<0.05). Additionally, after 4 days of culture we found in tissue explants both CD8+ (17.5[13.3;19.9]%) and CD8- (9.9 [6.4; 14]%) IFN--producing T-cells, however, their percentage, as well as the percentage of IL-2-producing T cells tended to decrease. After 19 days of culture explants of atherosclerotic plaques also contained lymphocytes (2830.1 [2350.3, 5900.2] cells/100mg tissue). Lymphocytes population included T cells (2594.5 [2035.7, 5306.7] cells/100mg tissue), presented by CD4+CD8- (1016.8 [671.2, 2201.7] cells/100mg tissue, 42.3 [34.3; 47.8]%) and CD4-CD8+ (1534.3 [813.8; 2207.2] cells/100mg tissue, 50.8 [45.6; 56.5]%) subsets, B cells (31 [18.3; 64.4] cell/100 mg tissue) and CD16+ NK cells (44.9 [33.4; 138.9] cells/100 mg of tissue).
An ex vivo model of human atherosclerotic plaque culture that we previously developed enables to preserve viability of various lymphocyte subsets for up to 19 days. We also found that cultured tissue explants retain T cells that can maintain T-helper-1-dependent immune response, which demonstrates inflammation in atherosclerotic plaques. Our results allow to perform experiments on immunological mechanisms of atherogenesis and to develop new approaches for treatment of atherosclerosis, devoted to the suppression of local inflammatory processes in atherosclerotic plaques.
An ex vivo model of human atherosclerotic plaque preserves CD4+CD8- and CD4-CD8+ T cells, B cells, and CD16+ NK cells for a long time. Moreover, after 4 days of culture tissue explants also retain IFN-++ T cells.
分析体外培养系统中人类动脉粥样硬化斑块淋巴细胞组成的动态变化。
本研究纳入了15例接受颈动脉内膜切除术患者的动脉粥样硬化斑块。根据先前开发的技术,将斑块作为环形外植体在特殊成分培养基中的胶原筏上于二氧化碳培养箱中培养。在培养第0天、第4天和第19天,我们从斑块外植体中提取细胞,并使用多色流式细胞术分析组织中的B淋巴细胞和T淋巴细胞含量,以及CD16 +自然杀伤(NK)细胞的百分比。为此,我们用一种原始酶混合物消化外植体,该混合物可保留细胞表面标志物,并用针对CD45、CD3、CD19、CD4、CD8、CD16的荧光标记单克隆抗体对提取的细胞进行染色。此外,我们通过流式细胞术估计产生白细胞介素2(IL-2)和干扰素-γ(IFN-γ)的T细胞数量。
培养4天后,斑块外植体中的淋巴细胞数量减少,但仍保留活淋巴细胞(2619.3 [1680.4, 3478.2]个细胞/100mg组织)。存活淋巴细胞群体包括T细胞(2123.4 [484.9; 3181.2]个细胞/100mg组织)、B细胞(5.6 [3.4, 27.9]个细胞/100mg组织)和CD16 + NK细胞(10.6 [1.8, 23.7]个细胞/100mg组织)。在培养第4天,T细胞由CD4 + CD8-(797 [475.5, 1000.7]个细胞/100mg组织,37.5 [32.1; 46.3]%)和CD4 - CD8 +(686.2 [423.6; 1158.4]个细胞/100mg组织,45.6 [38.1; 47.9]%)群体组成。与培养第1天相比,CD4 + CD8- T细胞群体的百分比降低,且这种降低与CD4 - CD8- T细胞含量的增加相关(p<0.05)。此外,培养4天后,我们在组织外植体中发现了产生IFN-γ的CD8 +(17.5[13.3;19.9]%)和CD8-(9.9 [6.4; 14]%)T细胞,然而,它们的百分比以及产生IL-2的T细胞的百分比趋于降低。培养19天后,动脉粥样硬化斑块外植体中也含有淋巴细胞(2830.1 [2350.3, 5900.2]个细胞/100mg组织)。淋巴细胞群体包括T细胞(2594.5 [2035.7, 5306.7]个细胞/100mg组织),由CD4 + CD8-(1016.8 [671.2, 2201.7]个细胞/100mg组织,42.3 [34.3; 47.8]%)和CD4 - CD8 +(1534.3 [813.8; 2207.2]个细胞/100mg组织,50.8 [45.6; 56.5]%)亚群组成,B细胞(31 [18.3; 64.4]个细胞/100mg组织)和CD16 + NK细胞(44.9 [33.4; 138.9]个细胞/100mg组织)。
我们先前开发的人类动脉粥样硬化斑块体外培养模型能够使各种淋巴细胞亚群的活力维持长达19天。我们还发现,培养的组织外植体保留了能够维持T辅助1型依赖性免疫反应的T细胞,这表明动脉粥样硬化斑块中存在炎症。我们的结果允许对动脉粥样硬化发生的免疫机制进行实验,并开发致力于抑制动脉粥样硬化斑块局部炎症过程的动脉粥样硬化治疗新方法。
人类动脉粥样硬化斑块体外模型可长期保留CD4 + CD8-和CD4 - CD8 + T细胞以及B细胞和CD16 + NK细胞。此外,培养4天后组织外植体也保留了产生IFN-γ的T细胞。